Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23552631 | 1.00 | PKN1 (0.34) | PKN1PKN2 | |
| SCHEMBL24800831 | 0.90 | — | — | |
| SCHEMBL23529329 | 0.90 | PKN1 (0.37) | PKN1PKN2 | |
| SCHEMBL24801693 | 0.85 | PKN1 (0.38) | PKN1PKN2 | |
| SCHEMBL29948114 | 0.85 | PKN1 (0.38) | PKN1PKN2 | |
| SCHEMBL23529335 | 0.85 | XDH (0.39) | — | |
| SCHEMBL23529388 | 0.85 | IDO1 (0.39) | — | |
| SCHEMBL23529311 | 0.84 | AGTR1 (0.42) | — | |
| SCHEMBL25095192 | 0.83 | PKN1 (0.33) | PKN1PKN2 | |
| SCHEMBL23529396 | 0.81 | GPR35 (0.35) | PKN1PKN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4077318-B1 | BENZIMIDAZOLE DIMERS AS MODULATORS OF STING | CTXT PTY LTD (AU) | 2025-10-15 | — | — | EP | claimed |
| CN-114981265-B | Compounds of formula (I) | CTXT私人有限公司 | 2025-01-03 | — | — | CN | claimed |
| EP-4077318-A1 | COMPOUNDS | CTXT PTY LTD (AU) | 2022-10-26 | — | — | EP | claimed |
| US-20260132112-A1 | COMPOUNDS | CTXT PTY LTD (AU) | 2026-05-14 | — | — | US | disclosed |
| US-12415785-B2 | Compound modulators of sting | CTXT PTY LTD (AU) | 2025-09-16 | — | — | US | disclosed |
| US-20230062932-A1 | COMPOUNDS | CTXT PTY LTD. (AU) | 2023-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12415785-B2 | Compound modulators of sting | STING1, IRF3, MAVS | PKN1 2995/4885PKN2 3870/4885 |
| US-20260132112-A1 | COMPOUNDS | STING1, IRF3, CGAS | PKN1 3602/4885PKN2 3792/4885 |
| US-20230062932-A1 | COMPOUNDS | STING1, IRF3, MAVS | PKN1 2987/4885PKN2 3800/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.